Candida albicans, Cryptococcus neoformans or Aspergillus fumigatus Induces an Antifungal Activity in Mouse Serum, which is Different from Transferrin

被引:2
作者
Okazaki, Ken-ichi [1 ]
Asakura, Masahiro [1 ]
Sugimoto, Norihiko [1 ]
Hinenoya, Atsushi [1 ]
Yamasaki, Shinji [1 ]
机构
[1] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5988531, Japan
关键词
antifungal activity; Aspergillus; Candida; Cryptococcus; Fungus; TUMOR-BEARING MICE; IMPROVES SURVIVAL; GROWTH; FLUID; INHIBITION; EPIDEMIOLOGY; MORTALITY; INFECTION; HOST;
D O I
10.1292/jvms.001459
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
It has been reported that administration of Candida albicans into mouse induces an antifungal activity in serum. which has been identified as transferrin. In the present study, we show that not only C. albicans, but also other fungus such as Cryptococcus neoformans or Aspergillus fumigatus similarly can induce all antifungal activity in mouse serum. This antifungal activity was inhibited by the addition of ferrous ion, indicating that the growth inhibition of C albicans was due to deficiency of ferrous ion, which may be caused by transferrin. Indeed, addition of transferrin in all in vitro assay System using RPM 11640 culture medium inhibited the growth of C albicans, C neoformans or A. fumigatus. However, when C albicans was grown in RPM11640 medium with 10% fetal bovine serum (FBS), transferrin was unable to inhibit the growth of C albicans, in sharp contrast, when C albicans treated mouse serum was added instead of FBS, the growth of the organism was inhibited. Similar results were obtained when C neoformans or A. fumigatus was used. Taken together, the results suggest that anti fungal activity induced by C. albicans, C. neoformans or A. fumigatus was not due to transferrin but likely due to other unknown serum proteins, which may cut off the Source of iron for the growth of these fungi.
引用
收藏
页码:1459 / 1464
页数:6
相关论文
共 32 条
[1]  
Abe F., 1989, Japanese Journal of Medical Mycology, V30, P254
[2]   EXPERIMENTAL CANDIDIASIS IN LIVER-INJURY [J].
ABE, F ;
NAGATA, S ;
HOTCHI, M .
MYCOPATHOLOGIA, 1987, 100 (01) :37-42
[3]   EXPERIMENTAL CANDIDIASIS IN IRON OVERLOAD [J].
ABE, F ;
TATEYMA, M ;
SHIBUYA, H ;
AZUMI, N ;
OMMURA, Y .
MYCOPATHOLOGIA, 1985, 89 (01) :59-63
[4]  
Abe S, 2000, Nihon Ishinkin Gakkai Zasshi, V41, P77, DOI 10.3314/jjmm.41.77
[5]   EVIDENCE FOR MACROPHAGE-MEDIATED PROTECTION AGAINST LETHAL CANDIDA-ALBICANS INFECTION [J].
BISTONI, F ;
VECCHIARELLI, A ;
CENCI, E ;
PUCCETTI, P ;
MARCONI, P ;
CASSONE, A .
INFECTION AND IMMUNITY, 1986, 51 (02) :668-674
[6]  
FINKELSTEIN RA, 1983, REV INFECT DIS S4, V5, P759
[7]  
GONZALEZCHAVEZ SA, 2008, INT J ANTIMICROB AG, V33, P301
[8]   Utilization of ferroproteins by Candida albicans during candidastasis by apotransferrin [J].
Han, Y .
ARCHIVES OF PHARMACAL RESEARCH, 2005, 28 (08) :963-969
[9]   Histopathological examination and analysis of mortality in DBA/2 mouse vasculitis induced with CAWS, a water-soluble extracellular polysaccharide fraction obtained from Candida albicans [J].
Hirata, Naoto ;
Ishibashi, Ken-Ichi ;
Ohta, Shin ;
Hata, Satoru ;
Shinohara, Hiroyasu ;
Kitamura, Mio ;
Miura, Noriko ;
Ohno, Naohito .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (08) :643-650
[10]   Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity [J].
Ibrahim, AS ;
Spellberg, BJ ;
Avenissian, V ;
Fu, Y ;
Filler, SG ;
Edwards, JE .
INFECTION AND IMMUNITY, 2005, 73 (02) :999-1005